MedPath

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

Phase 2
Completed
Conditions
Primary Insomnia
Registration Number
NCT00266344
Lead Sponsor
H. Lundbeck A/S
Brief Summary

A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
520
Inclusion Criteria
  • Patients with a diagnosis of primary insomnia
Exclusion Criteria
  • Patients with an active psychiatric disorder other than primary insomnia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Patient-reported total sleep time.
Secondary Outcome Measures
NameTimeMethod
Patient-reported time to sleep onset, number of awakenings, wake time after sleep onset and premature awakening.
© Copyright 2025. All Rights Reserved by MedPath